GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CFO Aaron Freidin sold 9,573 shares of the firm's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $50.17, for a total value of $480,277.41. Following the transaction, the chief financial officer directly owned 309,622 shares in the company, valued at approximately $15,533,735.74. This represents a 3.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
GRAIL Price Performance
Shares of GRAL opened at $52.76 on Wednesday. GRAIL, Inc. has a 1 year low of $20.44 and a 1 year high of $118.84. The stock has a 50 day simple moving average of $91.27 and a two-hundred day simple moving average of $77.46. The firm has a market cap of $2.06 billion, a P/E ratio of -4.72 and a beta of 5.18.
GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Thursday, February 19th. The company reported ($2.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.33) by $0.89. GRAIL had a negative net margin of 277.46% and a negative return on equity of 17.58%. The company had revenue of $43.60 million during the quarter, compared to analysts' expectations of $43.33 million. On average, equities analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the company. WIM INVESTMENT MANAGEMENT Ltd grew its stake in shares of GRAIL by 200.0% in the 3rd quarter. WIM INVESTMENT MANAGEMENT Ltd now owns 63,000 shares of the company's stock worth $3,725,000 after buying an additional 42,000 shares in the last quarter. Caxton Associates LLP bought a new position in GRAIL in the second quarter worth approximately $3,320,000. NWF Advisory Services Inc. purchased a new position in GRAIL during the 2nd quarter valued at about $1,062,000. Y Intercept Hong Kong Ltd bought a new stake in GRAIL during the 3rd quarter valued at $885,000. Finally, Legal Advantage Investments Inc. purchased a new stake in shares of GRAIL during the third quarter valued at about $1,242,000.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the stock. Canaccord Genuity Group decreased their price objective on shares of GRAIL from $105.00 to $80.00 and set a "buy" rating on the stock in a research report on Friday, February 20th. Weiss Ratings reissued a "sell (d-)" rating on shares of GRAIL in a research report on Thursday, January 22nd. TD Cowen initiated coverage on GRAIL in a research note on Thursday, February 19th. They issued a "hold" rating and a $114.00 price target on the stock. Guggenheim increased their price target on shares of GRAIL from $100.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, January 26th. Finally, Robert W. Baird set a $82.00 target price on shares of GRAIL in a report on Friday, February 20th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, GRAIL currently has an average rating of "Hold" and an average target price of $90.17.
Get Our Latest Analysis on GRAL
Trending Headlines about GRAIL
Here are the key news stories impacting GRAIL this week:
- Neutral Sentiment: GRAIL granted inducement restricted stock units covering 19,500 shares to 20 recently hired non‑executive employees under NASDAQ Rule 5635(c)(4). The award is small relative to market cap and appears intended to attract talent rather than materially dilute shareholders. GRAIL Announces Inducement Grants
- Neutral Sentiment: Reported short‑interest data contains obvious errors (shows 0 shares short and NaN changes), so it provides no reliable signal; treat the published short‑interest figures as suspect until corrected by the data provider or exchange.
- Negative Sentiment: Three senior executives sold shares on March 2: CEO Robert P. Ragusa sold 37,504 shares at an average price of $50.17 (~$1.88M), CFO Aaron Freidin sold 9,573 shares at $50.17 (~$480k), and President Joshua J. Ofman sold 17,002 shares at $50.16 (~$853k). Each sale reduced their holdings by a few percentage points. Insider selling can pressure sentiment (perception of executives taking gains or diversifying), though filings indicate these were disclosed transactions rather than unreported trades. SEC filings: Ragusa Form 4 Freidin Form 4 Ofman Form 4
- Negative Sentiment: Law firm Levi & Korsinsky announced an investigation into GRAIL over possible securities‑law violations tied to prior guidance statements (specifically CFO comments on cash‑burn guidance for 2025). Such probes can increase legal risk, create headline volatility, and prompt investor caution until details or outcomes are clarified. Levi & Korsinsky Investigation
GRAIL Company Profile
(
Get Free Report)
GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company's platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.
Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
